|
"pan sl"的相關文件
顯示項目 1-10 / 126 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-03-24 |
Identification and biological evaluation of a novel CLK4 inhibitor targeting alternative splicing in pancreatic cancer using structure-based virtual screening
|
Yang, CL;Wu, YW;Tu, HJ;Yeh, YH;Lin, TE;Sung, TY;Li, MC;Yen, SC;Hsieh, JH;Yu, MC;Hsieh, SY;Hsieh, HP;Pan, SL;Hsu, KC |
| 國家衛生研究院 |
2024-12 |
Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma
|
Shih, WH;Huang, HL;HuangFu, WC;Lin, TE;Sung, TY;Li, MC;Huang, GL;Chang, YW;Yen, SC;Hsieh, HP;Hsu, KC;Pan, SL |
| 國家衛生研究院 |
2024-11-07 |
Discovery of DYRK1A inhibitors as potential treatment of pancreatic ductal adenocarcinoma (PDAC)
|
Hsieh, HP;Zhang-Jian, YX;Hsu, KC;Pan, SL;Li, WS;Wu, HC |
| 國家衛生研究院 |
2023-02-07 |
Development of furanopyrimidine-based orally active third- generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 國家衛生研究院 |
2022-05-13 |
Evaluating the effectiveness of population-based breast cancer service screening: An analysis of parsimonious patient survival information with the time-varying Cox model
|
Chang, WJ;Jen, HH;Lin, KC;Cheng, TC;Chuang, SY;Pan, SL;Chen, HH;Yen, MF |
| 國家衛生研究院 |
2022-02-07 |
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 中山醫學大學 |
2020 |
Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library
|
Lee, YC; Huang, HT; Chang, CD; Chen, CT; Lin, TY; Yang, TW; Chang, FL; Lu, MK; Chiou, CT; Chen, WC; Pan, SL; Tsai, KC |
| 臺大學術典藏 |
2018-09-10T06:15:46Z |
Reduction of disability after stroke is a more informative predictor of long-time survival than initial disability status
|
Pan, S.-L. and Wu, S.-C. and Lee, T.-K. and Chen, T.H.-H.; Pan, SL;Wu, SC;Lee, TK;Chen, TH; Pan, SL; HSIU-HSI CHEN; SHIN-LIANG PAN; Wu, SC; Lee, TK; Chen, TH |
| 國家衛生研究院 |
2018-04 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
|
Lin, SY;Yeh, TK;Song, JS;Hung, MS;Cheng, MF;Liao, FY;Li, AS;Cheng, SY;Lin, LM;Chiu, CH;Wu, MH;Lin, YJ;Hsiao, W;Sun, M;Wang, YH;Huang, CH;Tang, YC;Chang, HH;Huang, ZT;Chao, YS;Shih, C;Pan, SL;Wu, SY;Kuo, CC;Ueng, SH |
| 國家衛生研究院 |
2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
|
Wang, HY;Chang, YL;Cheng, CC;Chao, MW;Lin, SI;Pan, SL;Hsu, CC;Liu, TW;Cheng, HC;Tseng, CP;Liu, SJ;Tsai, HJ;Chang, HY;Hsu, JT |
顯示項目 1-10 / 126 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
